Quantum Biopharma reported total assets of $14.39M and total liabilities of $8.30M for the quarter ended Jun 2026, down 5.9% year over year. This balance sheet covers 30 quarters of results from Dec 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2018 | Mar2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 39.32M | 35.26M | 28.57M | 31.62M | 23.75M | 16.98M | 9.22M | 5.67M | 3.63M | 2.76M | 1.33M | 3.31M | 3.12M | 6.00M | 3.52M | 1.50M | 0.45M | 1.91M | 4.34M | 3.65M | ||||||||||
| Short-term InvestmentsInvestments (Current) | 0.76M | 3.49M | ||||||||||||||||||||||||||||
| Cash & Current Investments | 39.32M | 35.26M | 28.57M | 31.62M | 23.75M | 16.98M | 9.22M | 5.67M | 3.63M | 3.51M | 1.33M | 3.31M | 6.61M | 6.00M | 3.52M | 1.50M | 0.45M | 1.91M | 4.34M | 3.65M | ||||||||||
| Receivables - NetNet Receivables | -0.21M | 0.50M | 0.37M | 0.22M | 0.23M | 0.23M | 0.23M | 0.09M | 0.10M | 0.37M | 0.39M | 0.19M | 0.08M | 0.23M | 0.21M | 0.11M | ||||||||||||||
| Receivables - OtherOther Receivables | 0.60M | 0.71M | 0.95M | 0.32M | 0.37M | 0.43M | 0.37M | 0.21M | 0.23M | 0.17M | 0.09M | 0.10M | 0.37M | 0.39M | 0.19M | 0.08M | 0.23M | 0.21M | 0.11M | |||||||||||
| Receivables | 0.40M | 0.50M | 0.75M | 0.65M | 0.60M | 0.44M | 0.46M | 0.17M | 0.21M | 0.75M | 0.79M | 0.39M | 0.16M | 0.46M | 0.42M | 0.22M | ||||||||||||||
| Raw Materials | 0.05M | 0.06M | 0.06M | |||||||||||||||||||||||||||
| Finished Goods | 0.07M | 0.02M | 0.02M | |||||||||||||||||||||||||||
| Inventory | 0.12M | 0.09M | 0.08M | 0.08M | 0.05M | 0.05M | 0.05M | |||||||||||||||||||||||
| Prepaid Assets | 1.35M | 1.37M | 1.58M | 1.44M | 1.06M | 0.47M | 0.84M | 0.50M | 0.35M | 0.16M | 0.27M | 0.13M | 0.15M | 0.07M | 0.14M | 0.45M | 0.04M | 0.02M | 0.08M | 0.06M | ||||||||||
| Current Assets | 45.93M | 55.17M | 50.81M | 43.22M | 17.85M | 18.83M | 11.09M | 10.02M | 13.84M | 12.05M | 9.93M | 10.34M | 9.34M | 6.48M | 10.37M | 9.96M | ||||||||||||||
| Non-Current Assets | ||||||||||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 0.01M | 0.02M | 0.11M | 0.11M | 0.10M | 0.10M | 0.09M | 0.09M | 0.08M | 0.06M | 0.06M | 0.08M | 0.07M | 0.07M | 0.07M | 0.07M | 0.06M | 0.06M | ||||||||||||
| Long-Term Investments | 1.50M | 0.86M | 0.12M | 0.30M | 0.30M | 0.23M | 0.65M | 0.55M | 0.74M | 0.76M | 0.76M | 0.02M | 0.01M | 1.20M | 0.02M | 0.03M | 0.64M | 0.46M | 0.22M | 0.21M | ||||||||||
| Intangibles | 17.30M | 16.20M | 15.38M | 14.27M | 13.16M | 12.04M | 10.47M | 5.57M | 5.46M | 5.36M | 5.25M | 5.15M | 5.04M | 4.93M | 4.83M | 4.73M | 4.62M | 4.51M | 4.41M | 4.30M | ||||||||||
| Goodwill & Intangibles | 17.30M | 16.20M | 15.38M | 14.27M | 13.16M | 12.04M | 10.47M | 5.57M | 5.46M | 5.36M | 5.25M | 5.15M | 5.04M | 4.93M | 4.83M | 4.73M | 4.62M | 4.51M | 4.41M | 4.30M | ||||||||||
| Long-Term Deferred Tax | 77.33M | 90.44M | 101.92M | 109.08M | 1.24M | |||||||||||||||||||||||||
| Other Non-Current Assets | 8.61M | 8.65M | 8.77M | |||||||||||||||||||||||||||
| Non-Current Assets | 0.66M | 0.54M | 0.36M | 0.37M | 0.83M | 0.11M | 0.01M | 0.01M | 0.01M | 0.01M | 0.00M | 0.00M | 4.95M | 4.81M | 4.56M | 4.43M | ||||||||||||||
| Assets | 68.67M | 62.96M | 55.71M | 51.17M | 43.58M | 38.41M | 29.48M | 21.41M | 18.94M | 17.47M | 15.25M | 19.03M | 17.12M | 14.87M | 15.30M | 14.15M | 11.16M | 14.93M | 14.39M | |||||||||||
| Liabilities | ||||||||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||||||||
| Accounts Payables | 6.69M | 7.51M | 7.87M | 7.66M | 6.49M | 7.11M | 7.71M | 5.32M | 3.70M | 4.20M | 3.29M | 4.42M | 3.31M | 4.36M | 2.36M | 3.19M | 4.09M | 4.18M | 3.59M | 3.38M | ||||||||||
| Notes Payables | 0.30M | 0.30M | 0.30M | 0.30M | 0.30M | 0.30M | 0.30M | 0.30M | 0.30M | 0.30M | 0.60M | 0.62M | 0.30M | 0.62M | 1.09M | 1.94M | 1.98M | 1.30M | 0.30M | 0.30M | ||||||||||
| Payables | 6.99M | 7.81M | 8.17M | 7.96M | 6.79M | 7.41M | 8.01M | 5.62M | 4.00M | 4.50M | 3.89M | 5.04M | 3.61M | 4.98M | 3.44M | 5.14M | 6.06M | 5.48M | 3.89M | 3.68M | ||||||||||
| Other Accumulated Expenses | ||||||||||||||||||||||||||||||
| Current Leases | 0.05M | 0.13M | 0.09M | 0.05M | 0.06M | 0.04M | 0.02M | 0.01M | ||||||||||||||||||||||
| Current Deferred Revenue | 1.00M | 1.00M | ||||||||||||||||||||||||||||
| Total Current Liabilities | 8.52M | 8.70M | 8.95M | 8.59M | 7.44M | 7.83M | 8.62M | 5.86M | 4.20M | 4.57M | 3.92M | 5.04M | 3.68M | 6.68M | 10.34M | 13.25M | 6.65M | 6.06M | 16.35M | 8.30M | ||||||||||
| Non-Current Liabilities | ||||||||||||||||||||||||||||||
| Convertible Debt | 0.15M | 0.16M | 0.16M | 0.43M | 0.47M | 0.49M | 0.60M | |||||||||||||||||||||||
| Minority Interest | -0.09M | -0.33M | -0.52M | -0.76M | -0.94M | -1.04M | -1.20M | -1.72M | -1.15M | -1.82M | -2.02M | -1.86M | ||||||||||||||||||
| Operating Leases | 0.05M | 0.12M | 0.16M | 0.16M | 0.20M | 0.18M | 0.14M | 0.11M | 0.06M | 0.04M | 0.02M | 0.01M | 0.07M | 0.05M | 0.04M | 0.16M | 0.15M | 0.10M | 0.08M | 0.06M | ||||||||||
| Other Non-Current Liabilities | 1.43M | 0.77M | 0.52M | 0.43M | 0.39M | 0.24M | 0.45M | 0.12M | 0.13M | 0.03M | 0.01M | 1.00 | 75.00 | 0.21M | 2.84M | 7.76M | 0.00M | 5.32M | 2.23M | |||||||||||
| Total Non-Current Liabilities | 7.09M | 8.07M | 8.43M | 8.16M | 7.05M | 0.08M | 8.17M | 5.74M | 4.06M | 6.06M | 11.03M | 6.07M | ||||||||||||||||||
| Total Liabilities | 8.52M | 8.83M | 8.95M | 8.59M | 7.44M | 7.87M | 8.62M | 5.86M | 4.20M | 4.57M | 5.04M | 3.68M | 6.68M | 10.34M | 13.25M | 5.50M | 6.06M | 16.35M | 8.30M | |||||||||||
| Shareholder's Equity | ||||||||||||||||||||||||||||||
| Total Debt | 0.30M | 0.30M | 0.30M | 0.30M | 0.30M | 0.30M | 0.30M | 0.30M | 0.30M | 0.30M | 0.60M | 0.62M | 0.30M | 0.62M | 1.09M | 1.94M | 1.98M | 1.30M | 0.30M | 0.30M | ||||||||||
| Common Equity | 60.15M | 54.13M | 46.76M | 42.58M | 36.14M | 30.54M | 20.86M | 15.55M | 14.75M | 12.91M | 11.51M | 10.20M | 15.35M | 10.44M | 4.53M | 2.05M | 8.65M | 5.10M | -1.42M | 6.09M | ||||||||||
| Liabilities and Shareholders Equity | 68.67M | 62.96M | 55.71M | 51.17M | 43.58M | 38.41M | 29.48M | 21.41M | 18.94M | 17.47M | 15.25M | 19.03M | 17.12M | 14.87M | 15.30M | 14.15M | 11.16M | 14.93M | 14.39M | |||||||||||
| Retained Earnings | -119.81M | -126.15M | -127.80M | -131.53M | -138.02M | -144.16M | -149.91M | -155.40M | -156.50M | -157.91M | -159.81M | -162.92M | -166.75M | -172.11M | -180.69M | -189.94M | -195.26M | -198.29M | -211.85M | -215.10M | ||||||||||
| Treasury Shares | -2.96M |
Pull Quantum Biopharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=QNTM&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "QNTM", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/statements?ticker=QNTM&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();